Instil Bio, Inc. Share Price Today: Live Updates & Key Insights

Instil Bio, Inc. share price today is $8.52, up 0.83%. The stock opened at $8.5 against the previous close of $8.48, with an intraday high of $8.5 and low of $8.38.

Instil Bio, Inc. Share Price Chart

Instil Bio, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Instil Bio, Inc. Share Price Performance

$8.52 0.0083(0.83%) TIL at 23 Mar 2026 03:30 PM Biotechnology
Lowest Today 8.38
Highest Today 8.5
Today’s Open 8.5
Prev. Close 8.48
52 Week High 42.79
52 Week Low 5.67
Day’s Range: Low 8.38 High 8.5
52-Week Range: Low 5.67 High 42.79
1 day return -
1 Week return +0.95
1 month return -6.85
3 month return -26.5
6 month return -56.36
1 year return -57.57
3 year return -30.96
5 year return -98.42
10 year return -

Instil Bio, Inc. Institutional Holdings

BML Capital Management LLC 9.52

Cpmg Inc 6.06

Vivo Capital, LLC 4.32

Millennium Management LLC 3.58

Siren, L.L.C. 3.01

Vanguard Group Inc 2.82

Sectoral Asset Management Inc 2.38

Vanguard Total Stock Mkt Idx Inv 1.75

Morgan Stanley - Brokerage Accounts 1.52

Renaissance Technologies Corp 1.00

BlackRock Inc 0.91

Dimensional Fund Advisors, Inc. 0.90

Macquarie Group Ltd 0.74

Nomura Healthcare Fund Class I 0.74

Citadel Advisors Llc 0.70

Geode Capital Management, LLC 0.63

Vanguard Institutional Extnd Mkt Idx Tr 0.62

Quest Partners LLC 0.55

LPL Financial Corp 0.49

Fidelity Extended Market Index 0.29

Quadrature Capital Limited 0.28

State Street Corp 0.26

Americana Partners, LLC 0.24

Northern Trust Corp 0.23

DFA US Small Cap I 0.15

iShares Micro-Cap ETF 0.14

Blackrock Extended Mkt Fund CF 0.13

T. Rowe Price Extended Equity Market Idx 0.13

Extended Equity Market Fund K 0.11

Avantis US Small Cap Equity ETF 0.11

DFA US Targeted Value I 0.10

Fidelity Total Market Index 0.10

Dimensional US Small Cap ETF 0.10

Fidelity Series Total Market Index 0.08

Spartan Extended Market Index Pool F 0.07

Protea Sectoral Biotech Opps IF USD Acc 0.07

Northern Trust Extended Eq Market Idx 0.06

NT Ext Equity Mkt Idx Fd - L 0.06

Vanguard Instl Ttl Stck Mkt Idx Tr 0.05

NT Ext Equity Mkt Idx Fd - NL 0.05

Instil Bio, Inc. Market Status

Strong Buy: 2

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

Instil Bio, Inc. Fundamentals

Market Cap 57.99 M

PB Ratio 0.4798

PE Ratio 0.0

Enterprise Value 63.03 M

Total Assets 263.57 M

Volume 27074

Instil Bio, Inc. Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:138000 0.1M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:138000 0.1M, FY19:null 0.0M

Annual Net worth FY23:-197006000 -197.0M, FY22:-223177000 -223.2M, FY21:-156794000 -156.8M, FY20:-37738000 -37.7M, FY19:-6454000 -6.5M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-12000 -0.0M, Q2/2025:-12000 -0.0M, Q1/2025:-498000 -0.5M, Q3/2024:null 0.0M, Q2/2024:-1000000 -1.0M

Quarterly Net worth Q3/2025:-13587000 -13.6M, Q2/2025:-21394000 -21.4M, Q1/2025:-28200000 -28.2M, Q3/2024:-23021000 -23.0M, Q2/2024:-14917000 -14.9M

About Instil Bio, Inc. & investment objective

Company Information Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. Its lead products candidate is AXN-2510/IMM2510 that is in Phase 1b/2 clinical trial for the treatment of patients with chemotherapy in patients with advanced/metastatic non-small cell lung cancer. The company also conducts a Phase 1 open label trial in China for AXN-2510/IMM2510 as monotherapy in patients with advanced solid tumors, including triple-negative breast cancer, squamous non-small cell lung cancer, hepatocellular carcinoma, renal cell carcinoma, and rare solid tumors, such as soft tissue sarcomas and thymic cancer. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Organisation Biotechnology

Employees 14

Industry Biotechnology

CEO Mr. Bronson Crouch

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Instil Bio, Inc. FAQs

What is the share price of Instil Bio, Inc. today?

The current share price of Instil Bio, Inc. is $8.52.

Can I buy Instil Bio, Inc. shares in India?

Yes, Indian investors can buy Instil Bio, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Instil Bio, Inc. shares in India?

You can easily invest in Instil Bio, Inc. shares from India by:

Can I buy fractional shares of Instil Bio, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Instil Bio, Inc.?

Instil Bio, Inc. has a market cap of $57.99 M.

In which sector does Instil Bio, Inc. belong?

Instil Bio, Inc. operates in the Biotechnology sector.

What documents are required to invest in Instil Bio, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Instil Bio, Inc.?

The PE ratio of Instil Bio, Inc. is N/A and the PB ratio is 0.48.